A couple of ARK Invest funds run by ETF star Cathie Wood made a huge buy on Wednesday. Specifically, these exchange-traded funds bought roughly $4.6 million worth of CRISPR Therapeutics AG (NASDAQ: CRSP), as the prices of these funds were down about 1% on Wednesday. Note that their performance is fairly negative in the past year.
[in-text-ad]
ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 14,400 shares of CRISPR, and ARK Innovation ETF (NYSEARCA: ARKK) scooped up 45,500 shares. At Wednesday’s closing price, this would have valued the sales at roughly $4.6 million altogether. Even though this is a small fraction of their total holdings, every little bit counts. The innovation ETF is down about 24% and the other is down closer to 36% in the past year.
Check out all the ARK Invest trades for Wednesday as well:
| Fund | Direction | Ticker | Name | Shares |
|---|---|---|---|---|
| ARKF | Buy | TDOC | TELADOC HEALTH | 10,000 |
| ARKG | Buy | TDOC | TELADOC HEALTH | 22,500 |
| ARKG | Buy | SGFY | SIGNIFY HEALTH | 105,770 |
| ARKG | Buy | PSNL | PERSONALIS | 33,753 |
| ARKG | Buy | MASS | 908 DEVICES | 56,909 |
| ARKG | Buy | CRSP | CRISPR THERAPEUTICS | 14,400 |
| ARKG | Buy | BLI | BERKELEY LIGHTS | 50,528 |
| ARKG | Buy | BEAM | BEAM THERAPEUTICS | 5,855 |
| ARKG | Sell | TXG | 10X GENOMICS | 33,989 |
| ARKG | Sell | VRTX | VERTEX PHARMACEUTICALS | 24,007 |
| ARKK | Buy | VCYT | VERACYTE | 38,715 |
| ARKK | Buy | TWOU | 2U | 107,448 |
| ARKK | Buy | TDOC | TELADOC HEALTH | 97,300 |
| ARKK | Buy | SSYS | STRATASYS | 249,771 |
| ARKK | Buy | NVTA | INVITAE | 51,355 |
| ARKK | Buy | CRSP | CRISPR THERAPEUTICS | 45,500 |
| ARKK | Sell | TSLA | TESLA | 22,816 |
| ARKQ | Buy | XPEV | XPENG | 43,100 |
| ARKQ | Buy | PATH | UIPATH | 31,830 |
| ARKQ | Buy | MTLS | MATERIALISE | 20,338 |
| ARKQ | Sell | TSLA | TESLA | 5,069 |
| ARKW | Buy | TDOC | TELADOC HEALTH | 17,000 |
| ARKX | Buy | BLDE | BLADE AIR MOBILITY | 28,372 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of a673b.bigscoots-temp.com.
Travel Cards Are Getting Too Good To Ignore
Credit card companies are pulling out all the stops, with the issuers are offering insane travel rewards and perks.
We’re talking huge sign-up bonuses, points on every purchase, and benefits like lounge access, travel credits, and free hotel nights. For travelers, these rewards can add up to thousands of dollars in flights, upgrades, and luxury experiences every year.
It’s like getting paid to travel — and it’s available to qualified borrowers who know where to look.
We’ve rounded up some of the best travel credit cards on the market. Click here to see the list. Don’t miss these offers — they won’t be this good forever.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.